ADVANSIX ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS

AdvanSix Inc. (ASIX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 News Release ADVANSIX ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS 3Q26 Sales of $431 million, up 15% versus prior year 3Q26 Earnings Per Share of ($0.28); Adjusted Earnings Per Share of ($0.24) 3Q26 Cash Flow from Operations of $48 million, up $21 million versus p

Original reporting
Published Nov 4, 2026, 11:31 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 11:35 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ASIX
Bearish
high confidence
Mentioned
$ASIX
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ASIXBearishHigh
01

Why it matters

The earnings release provides fresh guidance on sales growth, cash generation, and capital spending, shaping short‑term price expectations.

02

Market read

First‑report earnings data for a mid‑cap chemical producer, likely influencing its stock and peers.

03

What to watch

The new $425M credit facility provides liquidity that may mitigate near‑term concerns.

Relevance 7/10Novelty 8/10Timing: today

Background

AdvanSix is a vertically integrated chemistry company serving multiple end markets.

Company-level read

Ticker impact

$ASIXBearishHigh confidence
Context

AdvanSix reported Q3 2026 results with $431M sales, a loss of $0.28 EPS and a $48M cash flow from operations.

Expected impact

likely downside as investors price in the quarterly loss and lower EPS.

Evidence & confidence

The company posted a loss and reduced adjusted EBITDA, which typically triggers sell pressure even though cash flow rose.

Market effects

Chemicals sector may see modest pressure as a peer reports weaker earnings.

U.S. industrial chemicals stocks could face short-term downside.

Limited to niche chemical manufacturers; no broad market impact.

Counterpoint

Cash flow improvement and dividend declaration could support the stock if investors focus on balance sheet strength.

Key entities

  • AdvanSix Inc.

    Chemicals manufacturer reporting Q3 2026 results.

Related articles

Med

AdvanSix Inc. Q3 2026 Earnings Call Summary

AdvanSix Inc. reported Q3 2026 earnings, highlighting 17% favorable pricing offsetting $65M raw material cost increases. The company maintained high operating rates, optimized production, and reduced fixed costs. It expects Q4 price-over-raws headwinds and a 2027 ammonium sulfate supply shortage. AdvanSix secured a $47M USDA grant for Project CENTURY and closed a $425M credit facility.

$ASIXMedAI 8/10

AdvanSix (ASIX) Q3 2026 Earnings Call Transcript

AdvanSix (ASIX) reported Q3 2026 sales of $431M, up 15% YoY, driven by pricing. Adjusted EBITDA was $15M, down $10M YoY. Ammonia sales expected to rise 25% for the year. Nylon resin production up 5% YoY. Company focuses on cost reduction, operational excellence, and disciplined capital deployment.

$ASIXHigh

AdvanSix stock slips 2% on third quarter earnings miss

AdvanSix Inc. (ASIX) reported Q3 earnings that missed expectations, with an adjusted loss per share of -$0.24 vs. $0.28 estimate. Revenue was $430.81M, up 15% YoY. Stock fell 2% in pre-market trading. The company cited strong commercial execution and pricing strategies to offset inflation. Adjusted EBITDA declined to $14.6M, while cash flow improved to $48M. ASIX refinanced its credit facility and declared a $0.16 quarterly dividend.